{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:03:11Z","timestamp":1793138591939,"version":"4.5.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaneurol.2020.1484","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T15:40:09Z","timestamp":1592235609000},"page":"1122","source":"Crossref","is-referenced-by-count":403,"title":["Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy"],"prefix":"10.1001","volume":"77","author":[{"given":"Jerry R.","family":"Mendell","sequence":"first","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"},{"name":"Department of Neurology, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarife","family":"Sahenk","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"},{"name":"Department of Neurology, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Lehman","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Nease","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Lowes","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"},{"name":"Department of Neurology, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie F.","family":"Miller","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Iammarino","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay N.","family":"Alfano","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Nicholl","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiah","family":"Al-Zaidy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lewis","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Church","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda H.","family":"Cripe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael A.","family":"Potter","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pozsgai","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Dugar","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Vascular and Interventional Radiology, Nationwide Children's Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Rodino-Klapac","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital, Columbus, Ohio"},{"name":"Department of Pediatrics, The Ohio State University, Columbus"},{"name":"Sarepta Therapeutics Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi200033r1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"issue":"3","key":"noi200033r2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy.","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"issue":"4","key":"noi200033r3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/WNL.0000000000002891","article-title":"DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.","volume":"87","author":"Bello","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"noi200033r4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi200033r5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan.","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi200033r6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","article-title":"The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"noi200033r7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"11","key":"noi200033r8","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review.","volume":"39","author":"Rice","year":"2017","journal-title":"Clin Ther"},{"issue":"2","key":"noi200033r9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JND-180351","article-title":"Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy.","volume":"6","author":"Khan","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"noi200033r10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-61779-767-5_7","article-title":"Overview on DMD exon skipping.","volume":"867","author":"Aartsma-Rus","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"24","key":"noi200033r11","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production.","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"issue":"9791","key":"noi200033r12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"issue":"18","key":"noi200033r13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy.","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"noi200033r14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2019.05.005","article-title":"Impact of age and motor function in a phase 1\/2A study of infants with SMA type 1 receiving single-dose gene replacement therapy.","volume":"98","author":"Lowes","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"3","key":"noi200033r15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JND-190403","article-title":"AVXS-101 (onasemnogene abeparvovec) for SMA1: comparative study with a prospective natural history cohort.","volume":"6","author":"Al-Zaidy","year":"2019","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"noi200033r16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy.","volume":"26","author":"Duan","year":"2018","journal-title":"Mol Ther"},{"issue":"8","key":"noi200033r17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/hmg\/4.8.1245","article-title":"Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.","volume":"4","author":"Wells","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"6254","key":"noi200033r18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"issue":"17","key":"noi200033r19","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1093\/hmg\/ddw210","article-title":"Dystrophin contains multiple independent membrane-binding domains.","volume":"25","author":"Zhao","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"12","key":"noi200033r20","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/hmg\/ddy113","article-title":"Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins.","volume":"27","author":"Nelson","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"3","key":"noi200033r21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.","volume":"8","author":"Harper","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"noi200033r22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0014-5793(92)81265-N","article-title":"Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain.","volume":"308","author":"Suzuki","year":"1992","journal-title":"FEBS Lett"},{"issue":"2","key":"noi200033r23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.","volume":"15","author":"Salva","year":"2007","journal-title":"Mol Ther"},{"key":"noi200033r24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-5-45","article-title":"A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.","volume":"5","author":"Rodino-Klapac","year":"2007","journal-title":"J Transl Med"},{"issue":"3","key":"noi200033r25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ana.21732","article-title":"Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.","volume":"66","author":"Mendell","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"noi200033r27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The International Conference on Harmonization Good Clinical Practice guideline.","volume":"6","author":"Dixon","year":"1998","journal-title":"Qual Assur"},{"issue":"15","key":"noi200033r28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy.","volume":"363","author":"Mendell","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"noi200033r29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nmd.2017.02.007","article-title":"The 100-meter timed test: normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.","volume":"27","author":"Alfano","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"noi200033r30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"noi200033r31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.dysferlin overlap vectors restore function in dysferlinopathy animal models.","volume":"2","author":"Sondergaard","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"23","key":"noi200033r32","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1128\/JVI.79.23.14793-14803.2005","article-title":"Characterization of adeno-associated virus genomes isolated from human tissues.","volume":"79","author":"Schnepp","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"noi200033r33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mus.21945","article-title":"Suction-modified Bergstr\u00f6m muscle biopsy technique: experience with 13,500 procedures.","volume":"43","author":"Tarnopolsky","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"noi200033r34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10529410390262727","article-title":"Good clinical laboratory practice (GCLP): the need for a hybrid of good laboratory practice and good clinical practice guidelines\/standards for medical testing laboratories conducting clinical trials in developing countries.","volume":"10","author":"Stevens","year":"2003","journal-title":"Qual Assur"},{"issue":"1","key":"noi200033r35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.17925\/USN.2019.15.1.40","article-title":"Challenges of interpreting dystrophin content by western blot.","volume":"15","author":"Schnell","year":"2019","journal-title":"US Neurol"},{"issue":"18","key":"noi200033r36","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2006.10.078","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.","volume":"49","author":"Silva","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"noi200033r37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12968-015-0111-7","article-title":"Normal values for cardiovascular magnetic resonance in adults and children.","volume":"17","author":"Kawel-Boehm","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"noi200033r39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"issue":"25","key":"noi200033r40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"noi200033r41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00838159","article-title":"Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy.","volume":"240","author":"Doriguzzi","year":"1993","journal-title":"J Neurol"},{"issue":"2","key":"noi200033r42","first-page":"149","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.","volume":"87","author":"Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"noi200033r43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve"},{"issue":"3","key":"noi200033r44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.0b013e318225ab2e","article-title":"Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.","volume":"77","author":"Mazzone","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"noi200033r45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221097","article-title":"Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.","volume":"14","author":"Muntoni","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"noi200033r46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.","volume":"84","author":"Ricotti","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi200033r47","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.nmd.2019.06.251","article-title":"Estimating clinically meaningful change thresholds in the North Star Ambulatory Assessment (NSAA) and four-stair climb (4SC) in Duchenne muscular dystrophy (DMD).","volume":"29","author":"Wong","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"noi200033r26","author":"Potter","year":"2018"},{"key":"noi200033r38","unstructured":"A randomized, double-blind, placebo-controlled study of SRP-9001 for Duchenne muscular dystrophy (DMD). ClinicalTrials.gov Identifier: NCT03769116. Updated March 30, 2020. Accessed February 12, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03769116"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2767086\/jamaneurology_mendell_2020_oi_200033_1598965175.46323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T15:02:59Z","timestamp":1600095779000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2767086"}},"subtitle":["A Nonrandomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.1484","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}